Terminated NA INTERVENTIONAL NCT00164801

Effect of GABAB Agonist on Visceral Hyperalgesia in NCCP patientsChinese?

Is Visceral Hyperalgesia the Culprit of Noncardiac Chest Pain in Chinese? Part 2: Effect of GABAB Agonist on Visceral Hyperalgesia in NCCP Patients

Sponsor: Chinese University of Hong Kong

Conditions Non-Cardiac Chest Pain

Interventions Baclofen, Diltiazem

Updated 5 times since 2017 Last updated: Mar 25, 2008 Started: Nov 30, 2004 Completion: Jan 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Funding ended

Other terminated trials from Chinese University of Hong Kong

See all terminations from Chinese University of Hong Kong

Other Non-Cardiac Chest Pain trials with similar outcome

NCT00164814

Browse all Non-Cardiac Chest Pain trials

Listed as NCT00164801, this NA trial focuses on Non-Cardiac Chest Pain and remains terminated or withdrawn. Sponsored by Chinese University of Hong Kong, it has been updated 5 times since 2004, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA
Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

Nov 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chinese University of Hong Kong

Data source: Chinese University of Hong Kong

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hong Kong, China